Article Text

other Versions

PDF
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetric Graves ophthalmopathy
  1. Anja Eckstein (anja.eckstein{at}uk-essen.de),
  2. Christian Loesch (christian.loesch{at}uk-essen.de),
  3. Diana Glowacka (e_glowacka{at}o2.pl),
  4. Matthias Schott (schottmt{at}uni-duesseldorf.de),
  5. Klaus Mann (klaus.mann{at}uk-essen.de),
  6. Joachim Esser (joachim.esser{at}uni-essen.de),
  7. Nils G Morgenthaler (n.morgenthaler{at}brahms.de)
  1. Department of Ophthalmology, University of Essen, Germany
  2. Institute for Medical Informatics, Biometry and Epidemiology University of Essen, Germany
  3. Department of Ophthalmology, University of Essen, Germany
  4. Department of Medicine, Division of Endocrinology, University of Duesseldorf Germany, Germany
  5. Department of Medicine, Division of Endocrinology, University of Essen, Germany
  6. Department of Ophthalmology, University of Essen, Germany
  7. Endokrinologisches Forschungszentrum EnForCé, Charité, Berlin, Germany

    Abstract

    Background and aims: Retrospective, observational study to compare clinical symptoms and TSH-receptor antibodies (TRAb) in Graves' ophthalmopathy (GO) in euthyroid and primarily hypothyroid patients to those in hyperthyroid patients.

    Methods: Clinical symptoms (NOSPECS [severity] and CAS [activity] score), prevalence and levels of thyroid specific antibodies and the course of the disease were evaluated in 143 primarily hyperthyroid, 28 primarily euthyroid and 11 primarily hypothyroid patients with GO.

    Results: Patients with euthyroid/hypothyroid GO developed significantly less severe GO symptoms (NOSPECS score 4.4 versus 5.7; p=0.03), less active GO (CAS score 3.9 versus 5.2; p=0.002) and more asymmetric disease (proptosis side difference: 1.9mm versus 1.0mm [p=0.01]; side difference of ≥ 3mm: 23% versus 4.8%) than hyperthyroid patients. TRAb levels 6 months after GO onset were significantly lower (2.2 IU/l, p=0.02) in euthyroid/hypothyroid than in hyperthyroid patients (8.6 IU/l) as were prevalence of both TRAb and TPO antibodies (75% versus 94.6%, p=0.0008).

    Conclusions: The knowledge about the phenotype of GO in primarily euthyroid and hypothyroid patients is helpful for differential diagnosis and patient consultation. TRAb titres are very low in these patients, and the availability of a sensitive assay technique is therefore an important diagnostic tool in euthyroid and hypothyroid patients.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • At a glance
      Harminder S Dua Arun D Singh